About the Show
Hosted by Robert Bixby, Concord’s Senior Advisor and former Executive Director, the show dives into topics related to U.S. fiscal policy — like health care, taxes, national security, the national debt and more — with budget experts, industry leaders, elected officials and candidates for public office.
Listen to learn more about how the nation’s fiscal and economic challenges — and possible solutions — impact current and future generations.
The show is broadcast on Concord, New Hampshire radio station WKXL each week on Wednesdays at 3:00 p.m., with subsequent rebroadcasts on Saturdays at 9:00 a.m. and Sundays at 11:00 a.m.
This week on Facing the Future, we looked at various proposals on how to pay for the roughly $2 trillion social spending bill that Democrats hope to pass soon. These proposals include familiar ideas like raising rates on corporations…
This week on Facing the Future we took a step back from the day-to-day budget battles in Washington to consider the overall fiscal outlook. Our guest was Brian Riedl, a senior fellow at the Manhattan Institute, who recently published a…
This week on Facing the Future, we got a bipartisan view of a big week in Washington from two veteran Capitol Hill staffers, Bill Hoagland, senior vice president of the Bipartisan Policy Center, and Joe Minarik, senior vice president and director of…
This week on Facing the Future, we got a thorough briefing on the latest Social Security and Medicare Trustees’ Report from Dr. Charles Blahous, a former Public Trustee of both programs and now Senior Research Strategist at the Mercatus…
This week on Facing the Future our guest was Austin Smythe who has over 30 years of experience working in both the legislative and executive branches of the Federal government. Concord Coalition Policy Director Tori Gorman joined the conversation…
This week on Facing the Future, we turned to health care and the brewing controversy over Aduhelm, a new drug for treating Alzheimer's Disease that was recently approved by the Food and Drug Administration (FDA). Is it effective, will…